News

2015 WGND Annual Meeting and Reception


22 Nov 2015
by Working Group

Cape Town, South Africa, Dec. 5, 17:30 – 20:30

We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ Annual Meeting 2015 at Southern Sun Cape Sun Hotel, Cape Town, South Africa, on Saturday, Dec. 5th from 17:30 to 20:30.

This meeting is held before the 46th Union World Conference on Lung Health (The Union). During the meeting we will review and discuss progress of projects in the Global TB Drug Pipeline and Drug Discovery Portfolio, the new Global Plan, review WGND 2015 activities, and discuss other relevant topics. Representatives from pharmaceutical companies, research consortia and organizations, NGOs and academia will be participating.

2015 WGND ANNUAL MEETING

Agenda

17:30 – 17:35

Welcome Mel Spigelman

17:35 – 17:40

Stop TB Partnership, Global Plan Cherise Scott

17:40 – 17:50

TB Drug Development Year-in-Review Barbara Laughon
Global Pipeline Update

17:50 – 18:00

Janssen Myriam Haxaire

18:05 – 18:15

Clinical Trials Unit, MRC Andrew Nunn

18:20 – 18:30

TB Alliance Christo van Niekerk

18:35 – 18:45

AIDS Clinical Trials Group (ACTG) Susan Swindells

18:50 – 19:00

NIAID – Host-Directed Therapy Richard Hafner

19:05 – 19:15

University of Munich / EDCTP/PanACEA Michael Hoelscher & Martin Boeree

19:20 – 19:30

TB Trials Consortium (CDC) Neil Schluger
Looking Forward

19:35 – 19:50

Discussion of STOP TB Partnership Association Mel Spigelman, Cherise Scott, Barbara Laughon

19:50 – 20:30

Cocktail Reception WGND Members

Saturday, December 5th, 2015 | 17:30 – 20:30

Southern Sun Cape Sun Hotel| Cape Town, South Africa

Heavy hors d’oeuvres and drinks will be served.

Registration is free.

Please register by sending an e-mail reply to wgnd@newtbdrugs.org.

If you have any questions, please feel free to contact me.

Explore. Learn. Join the Conversation at www.newtbdrugs.org.
Best regards,

Cherise Scott, WGND Secretariat

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...